Home / Europe / Italy / Life Sciences & Healthcare

Life Sciences & Healthcare

CMS Adonnino Ascoli & Cavasola Scamoni has developed a broad expertise in the field of life sciences. Our life sciences & healthcare practice includes the assistance of clients which operate in the fields of pharmaceuticals, biotechnology medical devices and more generally health care services. We regularly advise life science & healthcare companies on corporate governance matters and licensing and contracts, as well as day-to-day corporate issues.

Our team can count on professionals “borrowed” on a regular basis, to life sciences from other departments of the firm including team of corporate and intellectual property professionals who can boast a significant experience securing and defending patent positions and regulatory law issues in order for companies to comply with the Italian regulatory law.

Choose area

colourful medical capsules
Pharmaceuticals
Today the pharmaceutical industry is rapidly growing. This is a highly complex industry and represents one of the fastest growing on the market. For t
Read more

Feed

22/11/2022
Glob­al Life Sci­ences & Health­care For­um 2022: Life Sci­ences are reap­ing...
Di­git­al trans­form­a­tion in life sci­ences is cre­at­ing op­por­tun­it­ies to counter health­care’s most in­tract­able prob­lems from treat­ing rare dis­eases to ac­cel­er­at­ing dia­gnostics and re­du­cing treat­ment back­logs...
Law-Now Life Sciences & Healthcare
09/11/2022
Glob­al Life Sci­ences & Health­care For­um 2022: The Life Sci­ences sec­tor...
The open­ing of COP27 has brought an in­tense glob­al fo­cus on cli­mate change and the tower­ing de­mands needed to reach car­bon net zero and to pro­tect the en­vir­on­ment. United Na­tions Gen­er­al Sec­ret­ary Ant­o­nio...
Law-Now Life Sciences & Healthcare
02/11/2022
Glob­al Life Sci­ences & Health­care For­um 2022: The leg­al sec­tor has a key...
The United Na­tions has pledged to use its pur­chas­ing fire­power to ac­cel­er­ate sus­tain­ab­il­ity along the health­care sup­ply chan­nel and called on the leg­al sec­tor to sup­port its ef­forts. Law­yers are crit­ic­al...
Law-Now Life Sciences & Healthcare
20/09/2022
Skin­teg­rated Cos­me­ceut­ic­als - is Pharma be­com­ing sexy (again?)
Case Study: Skin­tegra, Skin­teg­rity Cos­me­ceut­ic­als are sexy right now.  They’re less reg­u­lated than the phar­ma­ceut­ic­al in­dustry (al­though don’t let that fool you in­to be­liev­ing you can say whatever...
Law-Now Life Sciences & Healthcare
15/09/2022
Phar­ma­ceut­ic­al ad­vert­ising reg­u­la­tion and med­ic­al device ad­vert­ising in...
1. Which laws are ap­plic­able re­gard­ing ad­vert­ising of medi­cines and med­ic­al devices? Ad­vert­ising of medi­cines is reg­u­lated in a spe­cif­ic sec­tion of Le­gis­lat­ive De­cree no. 219/2006 (“Code of Medi­cines”)...
Expert Guide Life Sciences & Healthcare
13/09/2022
UPC Rules of Pro­ced­ure go in­to force with judg­ments to be made pub­lic
The entry in­to force of the Rules of Pro­ced­ure is part of the fi­nal pre­par­a­tions for the United Pat­ent Court (UPC), which is cur­rently ex­pec­ted to start work in early 2023. After the bod­ies of the UPC...
Law-Now Life Sciences & Healthcare
08/09/2022
Can­nabis law and le­gis­la­tion in Italy
Med­ic­al use Grow­ing, selling and im­port­ing med­ic­al can­nabis is al­lowed on the con­di­tion that the au­thor­isa­tion of the Min­istry of Health is ob­tained. Cul­tiv­a­tion, sale and im­port are cur­rently mainly...
Expert Guide Life Sciences & Healthcare
30/08/2022
Phar­ma­ceut­ic­al trade marks - a real pain in the bum?
An EU IPO Case Study: Proc­to­LYSY­AL v PRO­COTOL­IZ­IN Sum­mary I al­ways like to start at the end.  No nasty sur­prises and you know what to ex­pect.  In this case study, the trade marks ‘proc­to­LYSY­AL’...
Law-Now Life Sciences & Healthcare
02/08/2022
Leg­al is­sues in the meta­verse / Part 4 - Ex­pec­ted im­pact of the EU Ar­ti­fi­cial...
Part 4 - Ex­pec­ted im­pact of the EU Ar­ti­fi­cial In­tel­li­gence Reg­u­la­tion, the meta­verse as a work­place In our first art­icle, we ex­amined the nature of the meta­verse, the shared vir­tu­al world. The emer­gence...
Law-Now Insurance
27/07/2022
Leg­al is­sues in the meta­verse / Part 3 - Data pro­tec­tion chal­lenges, the...
Part 3 - Data pro­tec­tion chal­lenges, the im­port­ance of cy­ber­se­cur­ity, ad­vert­ising reg­u­la­tion in the meta­verse In our first art­icle, we ex­amined the nature of the meta­verse, the shared vir­tu­al world...
Law-Now Insurance
26/07/2022
European Bolar Pro­vi­sions in Italy
1. How is Bolar im­ple­men­ted? The Bolar ex­cep­tion provided for by Art. 10 of Dir­ect­ive 2001/83 has been im­ple­men­ted in Italy by means of Art. 68(1)(b) of Le­gis­lat­ive De­cree No. 30 of 2005 (the “IP...
Expert Guide Intellectual Property
Comparable
19/07/2022
Leg­al is­sues in the meta­verse / Part 2 - Trade­marks and copy­right, NFTs...
Part 2 - Trade­marks and copy­right, NFTs and civil law prin­ciples in the meta­verse In our first art­icle, we ex­amined the nature of the meta­verse, the shared vir­tu­al world. In the meta­verse, trade in vir­tu­al...
Law-Now Insurance
Load more articles